1-3 of 3
permissible exposure limit
Close
Save search
Sort by
Journal Articles

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases

Free
Clinical Trials & Observations
Ramya Ramaswami, Kathryn Lurain, Mark N. Polizzotto, Irene Ekwede, Kirsta Waldon, Seth M. Steinberg, Ralph Mangusan, Anaida Widell, Adam Rupert, Jomy George, Priscila H. Gonçalves, Vickie A. Marshall, Denise Whitby, Hao-Wei Wang, Stefania Pittaluga, Elaine S. Jaffe, Richard F. Little, Thomas S. Uldrick, Robert Yarchoan
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1660–1670.
https://doi.org/10.1182/bloodadvances.2020004058
Published: 2021
Includes: Supplemental data
Journal Articles

Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma

Free
Ajinkya Patil, Mark Manzano, Eva Gottwein
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2105–2117.
https://doi.org/10.1182/bloodadvances.2019031732
Published: 2019
Includes: Supplemental data
Journal Articles

Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma

Free
Clinical Trials & Observations
Victoria A. Chang, Huan-You Wang, Erin G. Reid
Journal: Blood Advances
Blood Adv (2019) 3 (5): 766–768.
https://doi.org/10.1182/bloodadvances.2018026351
Published: 2019